Hodgkin's lymphoma Posts Page 2 on Medivizor
Navigation Menu

Hodgkin’s lymphoma Posts on Medivizor

The impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned stem cell transplant

Posted by on Mar 26, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study aimed to investigate the impact of the graft-versus-lymphoma effect on the outcomes for patients with lymphoma who are treated with reduced-intensity conditioning (RIC) with alemtuzumab (Lemtrada) allogeneic hematopoietic stem cell transplant (allo-HSCT). This study concluded that the graft-versus-lymphoma effect leads...

Read More

Is nivolumab an effective treatment for relapsed and unresponsive Hodgkin lymphoma?

Posted by on Mar 16, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined if nivolumab is an effective treatment for relapsed and unresponsive Hodgkin lymphoma. This study concluded that nivolumab is an effective treatment for these patients, regardless of previous stem cell treatment status. Some background Standard treatment for patients with Hodgkin lymphoma (HL) which has relapsed or...

Read More

Evaluating the impact of interim imaging on treatment outcomes for advanced cHL

Posted by on Mar 10, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study investigated the impact of interim functional imaging (IFI) on the outcomes of treatment for advanced classical Hodgkin lymphoma (cHL). This study found that patients with positive scan results were more likely to disease progression. Some background ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) is the...

Read More

Does bone Hodgkin lymphoma affect survival in patients with Hodgkin lymphoma?

Posted by on Feb 19, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study investigated if patients with Hodgkin lymphoma (HL) found in the bones have worse outcomes than patients with HL in the lymph nodes. It was found that having bone HL did not reduce survival of patients. Some background Many patients with HL are cured by treatment. After 5 years, almost 86% of patients survive. When...

Read More

Evaluating A+AVD for patients with newly diagnosed advanced Hodgkin lymphoma

Posted by on Feb 17, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of brentuximab vedotin (Adcetris) plus chemotherapy for patients with advanced (stage 3 – 4) Hodgkin’s lymphoma (HL). This study concluded that this treatment is effective for these patients. Some background The most commonly used frontline chemotherapy regimen for advanced HL...

Read More

Oncolytic Virus Treatments

Oncolytic Virus Treatments

Posted by on Feb 10, 2019 in Blog, Breast cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Prostate cancer | 0 comments

In 1904, a physician wrote about a patient with leukemia who went into remission when he got the flu. Though the patient was not cured, it was a ray of hope at a time when there were no treatments for leukemia. Other cases were reported throughout the years of people with Burkitt’s Lymphoma and Hodgkin’s Lymphoma going into remission when they...

Read More

Is BRESHAP an effective treatment for relapsed and unresponsive Hodgkin lymphoma?

Posted by on Feb 8, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined how safe and effective brentuximab vedotin (Adcedris) is when added to conventional treatments for relapsed and unresponsive Hodgkin lymphoma.  This study concluded that this treatment is safe and effective when used as part of the treatment for Hodgkin lymphoma. Some background Standard treatment for...

Read More